Exposure to febrile temperature upregulates expression of pyrogenic cytokines in endotoxin-challenged mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Jiang, Qingqi ^a   Detolla, Louis ^a   Singh, Ishwar S ^a,b   Gatdula, Lisa ^a,b,c   Fitzgerald, Bridget ^a,b,c   Van Rooijen, Nico ^d   Cross, Alan S ^a   Hasday, Jeffrey D ^a,b,c,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Baltimore Cytokine Core Laboratory   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Body temperature; Fever; Heat shock proteins; Interleukin 1; Interleukin 6; Kupffer cells; Tumor necrosis factor

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PYROGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BATH; BODY TEMPERATURE; CONTROLLED STUDY; CORE TEMPERATURE; CYTOKINE PRODUCTION; FEVER; IMMUNE RESPONSE; INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033000352     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.6.r1653     Document Type: Article

References (35)

1. Aderka, D., J. Le, and J. Vilcek. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143: 3517-3523, 1989.
2. Akins, C., D. Thiessen, and R. Cocke. Lipopolysaccharide increases ambient temperature preference in C57BL/6J adult mice. Physiol. Behav. 50: 461-463, 1991.
3. Arditi, M., J. Zhou, R. Dorio, G. W. Rong, S. M. Goyert, and K. S. Kim. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61: 3149-3156, 1993.
4. Armstrong, C. Some recent research in the field of neurotropic viruses with special reference to lymphocytic choriomeningitis and herpes simplex. Milit. Surg. 91: 129-145, 1942.
5. Baumann, H., and J. Gauldie. The acute phase response. Immunol. Today 15: 74-80, 1994.
6. Bell, J. F., and G. F. Moore. Effects of high ambient temperature on various stages of rabies virus infection in mice. Infect. Immun. 10: 510-515, 1974.
7. Blake, D., P. Bessey, I. Karl, I. Nunnally, and R. Hotchkiss. Hyperthermia induces IL-1α or TNF-α after endotoxin. Lymphokine Cytokine Res. 13: 271-275, 1994.
8. Bone, R. C., C. J. J. Fisher, T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk. Sepsis syndrome: a valid clinical entity. Crit. Care Med. 17: 389-393, 1989.
9. Brand, J. M., H. Kirchner, C. Poppe, and P. Schmucker. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin. Immunol. Immunopathol. 83: 190-194, 1997.
10. Bryant, R. E., A. F. Hood, C. E. Hood, and M. G. Koenig. Factors affecting mortality of gram-negative rod bacteremia. Arch. Intern. Med. 127: 120-128, 1971.
11. Chu, E. K., S. P. Ribeiro, and A. S. Slutsky. Heat stress increases survival rates in lipopolysaccharide-stimulated rats. Crit. Care Med. 25: 1727-1732, 1997.
12. Cross, A., L. Asher, M. Seguin, L. Yuan, N. Kelly, C. Hammack, and J. Sadoff. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Invest. 96: 676-686, 1995.
13. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149: 1666-1670, 1992.
14. Dorn, T. F., C. DeAngelis, R. A. Baumgardner, and E. D. Mellits. Acetaminophen: more harm than good for chicken pox? J. Pediatr. 114: 1045-1048, 1989.
15. Ensor, J. E., E. K. Crawford, and J. D. Hasday. Warming macrophages to febrile range destabilizes tumor necrosis factor-α mRNA without inducing heat shock. Am. J. Physiol. 269 (Cell Physiol. 38): C1140-C1146, 1995.
16. Ensor, J. E., S. M. Wiener, K. A. McCrea, R. M. Viscardi, E. K. Crawford, and J. D. Hasday. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am. J. Physiol. 266 (Cell Physiol. 35): C967-C974, 1994.
17. Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H. Baumann. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84: 7251-7255, 1987.
18. Habicht, G. S. Body temperature in normal and endotoxin-treated mice of different ages. Mech. Ageing Dev. 16: 97-104, 1981.
19. Hasday, J. D. The influence of temperature on host defenses. In: Fever: Basic Mechanisms and Management (2nd. ed.), edited by P. A. Mackowiak. New York: Raven, 1996, p. 87-116.
20. Hirano, T. Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 62: S60-S65, 1992.
21. Jiang, Q., L. DeTolla, I. Kalvakolanu. N. Van Roojien, I. S. Singh, B. Fitzgerald, A. S. Cross, and J. D. Hasday. Febrile range temperature modifies early systemic TNFa expression in bacterial endotoxin-challenged mice. Infect. Immun. 67: 1539-1546, 1999.
22. Kluger, M. J., W. Kozak, C. A. Conn, L. R. Leon, and D. Soszynski. The adaptive value of fever. In: Fever: Basic Mechanisms and Management (2nd ed.), edited by P. A. Mackowiak. New York: Raven, 1996, p. 255-266.
23. Kluger, M. J., K. Rudolph, D. Soszynski, C. A. Conn, L. R. Leon, W. Kozak, E. S. Wallen, and P. L. Moseley. Effect of heat stress on LPS-induced fever and tumor necrosis factor. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R858-R863, 1997.
24. Knochel, J. P., and E. L. Goodman. Heat stroke and other forms of hyperthermia. Elevations in body temperature not mediated by endogenous pyrogens. In: Fever, Basic Mechanisms and Management (2nd ed.), edited by P. A. Mackowiak. Philadelphia, PA: Lippincott-Raven, 1997, p. 437-457.
25. Mackowiak, P. A., S. S. Wasserman, and M. M. Levine. An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis. J. Infect. Dis. 166: 1181-1184, 1992.
26. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. Old. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098, 1997.
27. Reinhat, K., K. Eyrich, and C. Sprung. Sepsis: Current Perspectives in Pathophysiology and Therapy. New York: Springer-Verlag, 1994.
28. Shalaby, M. R., A. Waage, and T. Espevik. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell. Immunol. 121: 372-382, 1989.
29. Shenep, J. L., P. M. Flynn, F. F. Barrett, G. L. Stidham, and D. F. Westenkirchner. Serial quantitation of endotoxemia and bacteremia during therapy for Gram-negative bacterial sepsis. J. Infect. Dis. 157: 565-568, 1988.
30. Tracey, K., B. Beutler, S. Lowry, J. Merryweather, S. Wolpe, I. Milsark, R. Hariri, T. Fahey III, A. Zentella, J. Albert, G. Shires, and A. Cerami. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986.
31. Van Rooijen, N., and A. Sanders. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93, 1994.
32. Van Rooijen, N., and A. Sanders. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology 23: 1239-1243, 1996.
33. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169: 333-338, 1989.
34. Waage, A., and T. Espevik. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J. Exp. Med. 167: 1987-1992, 1988.
35. Xing, Z., J. Gauldie, G. Cox, H. Baumann, M. Jordana, X. Lei, and M. Achong. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101: 311-320, 1998.